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RelA/NF-jB recruitment on the bax gene promoter
antagonizes p73-dependent apoptosis in costimulated
T cells
R Cianfrocca1, M Muscolini1, V Marzano1, A Annibaldi1, B Marinari2, M Levrero3,4, A Costanzo*,2,4 and L Tuosto*,1
The balance between antiapoptotic and proapoptotic proteins of the Bcl-2 family is critical in determining the fate of T cells in
response to death stimuli. Proapoptotic genes, such as bax, are generally regulated by the p53 family of transcription factors,
whereas NF-jB subunits can activate the transcription of antiapoptotic Bcl-2 members. Here, we show that CD28 activation
protects memory T cells from irradiation-induced apoptosis by both upregulating bcl-xL and inhibiting bax gene expression. We
found that p73, but not p53, binds to and trans-activates the bax gene promoter in irradiated T cells. The activation of RelA/NF-jB
subunit in CD28 costimulated T cells and its binding onto the bax gene promoter results in suppression of bax transcription and
decrease in both p73 and RNA polymerase II recruitment in vivo. RelA recruitment on the bax gene promoter is also accompanied
by the lost of p300 binding and the parallel appearance of histone deacetylase-1-containing complexes. These findings identify
RelA/NF-jB as a critical regulator of T-cell survival by affecting the balance of Bcl-2 family members.
Cell Death and Differentiation (2008) 15, 354–363; doi:10.1038/sj.cdd.4402264; published online 23 November 2007
Apoptosis of T lymphocytes is a physiological mechanism by
which an efficient immune system prevents autoimmunity and
ensures T-cell homeostasis.1 The regulation of Bcl-2 family
proteins represents a critical checkpoint in the apoptotic
pathway and is important to determine the cell fate in the
lymphoid system. The Bcl-2 family comprises multidomain
proteins with antiapoptotic (Bcl-2, Bcl-xL, Bcl-W, 1, A1Bfl-1)
and proapoptotic functions (Bax, Bak, Bid, Bim, Hrk), and a
subset of proapoptotic members known as BH3-only proteins
with regulatory functions. The BH3-only proteins (i.e., Bid,
Bad, Bim, Noxa, Puma) communicate both extrinsic (death
receptor, growth factor, T-cell receptor (TCR)) and intrinsic
death stimuli (DNA damage) to Bax and Bak favoring their
oligomerization, the release of cytochrome c from the
mitochondrial membrane and subsequently inducing cell
death. The balance between proapoptotic (Bax, Bak) and
antiapoptotic members (Bcl-2, Bcl-xL) determines how the
cell will respond to an apoptotic signal.2,3 Indeed, antiapopto-
tic members of the Bcl-2 family may sequester the proapop-
totic proteins, thus preventing mitochondrial damage and
apoptosis.4 In summary, the downregulation of antiapoptotic
and the induction of proapoptotic members of the Bcl-2 family,
such as Bax, are required to activate the cell death programs.
The transcription factor NF-kB can be considered a major
regulator of lymphocyte survival. In mammals, this family
consists of five members that form homo- and heterodimeric
complexes, including NF-kB1 (p50 and its precursor p105),
NF-kB2 (p52 and its precursor p100), RelA (p65), RelB and
c-Rel. RelA, RelB and c-Rel contain trans-activating domains
(TADs) and are able to activate transcription. p50 and p52
lack a TAD and therefore may form transcriptionally active
heterodimers in association with RelA, RelB and c-Rel.5 NF-kB
activity is regulated by inhibitory proteins belonging to the IkB
family (which include IkBa, IkBb and IkBe), with the function to
retain NF-kB dimers in the cytoplasm. A protein kinase
complex, known as IKK signalsome, phosphorylates IkBa,
IkBb and IkBe, inducing their proteolytic degradation and the
subsequent translocation of NF-kB into the nucleus.6
NF-kB activation can suppress cell death pathways through
the transcriptional activation of the Bcl-2 homologues A1/Bfl-1
and Bcl-xL. Recently, NF-kB has been also involved in the
downregulation of Bax expression, in some human cancers
(colon, breast and ovarian cancer cell lines)7 and in Epstein–
Barr virus-infected B cells.8 Transcription of the bax gene is
controlled by several transcription factors, including the tumor
suppressor proteins belonging to p53 family.9 Bax promoter
contains a DNA consensus sequence for binding of the tumor
suppressor protein p53. Exogenously expressed p53 in-
creases bax expression in several cell types, and this increase
correlates with the induction of apoptosis.10 In some cell lines,
p53 binds the bax gene promoter weakly when compared with
other target promoters (i.e., puma), suggesting that bax may
not represent the major target gene for p53.11 Recently,
another member of the p53 family, p73, with trans-activating
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potential on the bax gene promoter has been identified. p73
is expressed in multiple isoforms (p73 a–z), derived from
alternative splicing at the 30.12,13 Interestingly, whereas p53
serves as a checkpoint protein for DNA damage, p73
integrates stimuli for both DNA damage and receptor-
mediated apoptosis in T cells.14 A connection between p73
and the NF-kB pathway has been recently proposed in T
lymphocytes, where costimulation-induced NF-kB activity
has been related to the inhibition of p73 expression.15 Thus,
an interplay between NF-kB and p73 exists that may play an
important role in regulating the fate of T lymphocytes.
Here, we report that CD28 engagement by B7 protects
memory T cells from irradiation-induced apoptosis, by
modulating the expression of both anti- and proapoptotic
proteins of the Bcl-2 family. We found that in irradiated T cells
p73, but not p53, binds to and trans-activates the bax gene
promoter and that CD28 costimulation inhibits p73-induced
bax transcription. The RelA/NF-kB subunit in CD28-costimu-
lated T cells suppresses bax gene transcription by a direct
binding to the bax gene promoter and interferes with the
recruitment of both p73 and RNA polymerase II (pol II). Data
obtained by using specific inhibitors evidenced the involve-
ment of PI3K/Akt pathway in CD28-mediated inhibition of both
Bax expression and apoptosis. These findings reveal a new
mechanism by which NF-kB can promote T-cell survival.
Results
CD28 costimulation protects T cells from radiation-
induced apoptosis by regulating both bcl-xL and bax
transcriptional activation. We have recently demonstrated
that CD28 ligation by B7 in the absence of TCR stimulation
protects memory T cells from ionizing radiation (IR)-induced
apoptosis and induces the recruitment of RelA on the bcl-xL
gene promoter, thus upregulating Bcl-xL expression16
(Supplementary Figure 1). Starting from these data, we
analyzed the effects of CD28-mediated survival signals on
the expression of proapoptotic genes. In particular, we
looked at the transcription of bim, puma and bax genes,
being the major mediators of mitochondria-dependent
apoptosis. Bax gene transcription was induced as early as
2 h post irradiation and started to decrease after 8 h
(Figure 1a). By contrast, bim and puma expressions, which
were efficiently upregulated in PMA-treated human memory
T cells, were not induced following IR treatment (Figure 1a,
middle panels). CD28 stimulation strongly inhibited bax
(Figure 1a, lanes 4 and 5 versus 2 and 3). Consistently
with our recent data,16 bcl-xL gene expression was induced
8 h after CD28 engagement (Figure 1a, upper panel, lane 5).
Bax gene transcription was also accompanied by a strong
increase of Bax protein levels, which were significantly
reduced following CD28 stimulation (Figure 1b, upper
panel). We also analyzed the expression of both p53 and
p73 proteins, being involved in the regulation of proapoptotic
gene expression during IR-induced apoptosis.17,18 We found
that primary T cells expressed basal protein levels of p73,
which did not change following irradiation (Figure 1b, middle
panel). On the basis of its molecular weight (B80 kDa) and
co-migration with exogenously expressed HA-p73a
(Supplementary Figure 3, lower panel), the p73 isoform
found in T cells is likely p73a. Although no significant
changes in p73 protein levels were observed in IR-treated
T cells, data obtained from radioactive RT-PCR evidenced
an early (2 h after IR) and transient induction of p73a
transcription that was completely inhibited following CD28
stimulation (Figure 1c, upper panel). By contrast, p53 levels
were strongly induced after IR and were not affected by
CD28 (Figure 1b, middle panel). No change in RelA content
was observed in IR-treated cells (Figure 1b, lower panel).
The analysis of bax gene promoter occupancy by chromatin
immunoprecipitation (ChIP) experiments revealed that p73
was recruited on the promoter in the early phase of IR-induced
transcriptional activation (Figure 1d, upper panel, lanes 1–3).
By contrast, endogenous p53 did not bind the bax gene
promoter in irradiated T cells (Figure 1d, middle panel),
although it was recruited on to the DNp73 promoter and
efficiently trans-activated it (Figure 3c and d). The induction
of DNp73 expression by p53 has been described to create
dominant-negative feedback loop that fine tunes the function
of p53.19 The relevance of p73 in IR-induced apoptosis was
evidenced by the silencing with oligonucleotide small inter-
fering RNA (siRNA) duplexes, which specifically downregu-
late the expression of several p73 isoforms (Figure 2b). As
shown in Figure 2a, the inhibition of p73 expression was
associated with a significant reduction (around 40%) of
IR-induced apoptosis (Figure 2a). By contrast, the down-
regulation of p53 (Supplementary Figure 2b) obtained by
transfecting cells with two p53 siRNA duplexes did not affect
IR-induced apoptosis (Supplementary Figure 2b). Similarly to
p73, silencing of bax transcript significantly protects cells from
IR-induced apoptosis (Supplementary Figure 2c and d).
Unrelated siRNA (ctr) did not exert any significant effect.
CD28 stimulation significantly inhibited p73 and RNA pol II
recruitment on the bax gene promoter (Figure 2c, upper and
middle panels, lanes 4 and 5 versus 2 and 3). The loss of both
p73 and RNA pol II bindings correlated with the recruitment
of RelA on the bax gene promoter in CD28-stimulated cells
(Figure 2d, upper panels). Consistently with our previous
data,16 RelA was recruited on and trans-activated the bcl-xL
gene promoter (Figure 2d, middle panel, lanes 4 and 5).
Altogether these data indicate that the in vivo recruitment of
RelA/NF-kB on the bax gene promoter in CD28-costimulated
T lymphocytes is paralleled by a decrease in IR-induced p73
recruitment and transcriptional activity.
The bax gene promoter is trans-activated by p73, but
not p53, in Jurkat cells. To further define the role of p73 in
the trans-activation of the bax gene promoter, we used a
Jurkat T cell line that expresses endogenous p73, but not
detectable p53, undergoes apoptosis and upregulates Bax
after IR (data not shown). Jurkat cells were transfected with a
bax-luciferase reporter construct, containing the luciferase
gene under the control of the bax promoter (715 to
317 bp), in the presence of either HA-tagged p73 (ad) or
Flag-p53 expression vectors. All the p73 isoforms were able
to trans-activate the bax promoter, although to different
degrees (Figure 3a), with p73a and p73g being the most
potent trans-activators. By contrast, p53 did not significantly
upregulated bax expression under the same experimental
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conditions, although it was able to bind and trans-activate the
DNp73 promoter both in vitro (Figure 3c) and in IR T cells
(Figure 3d). Similar results were obtained in another T cell
line (Hut-78), thus indicating that in T cells p53 does not
regulate bax transcription as observed in other cancer cell
lines10 (data not shown).
The bax gene promoter contains four potential p53-binding
sites. These binding sites reside within a 39-bp region (486
to –448 bp) that has been identified as sufficient for p53-
mediated trans-activation10 and to bind exogenous HA-p73a
in EMSA assays (data not shown). Consistently with the high
homology shared by p53 and p73 in their DNA-binding domain
as well as in their ability to activate largely overlapping sets
of genes,9 p73-induced bax transcription depended on the
presence of its TAD, as demonstrated by the inability of a p73a
mutant (D85p73a), lacking the TAD, to significantly upregulate
bax-luciferase activity (Figure 4a). Furthermore, p73awas not
able to trans-activate the mutp53 bax-luciferase vector
(Figure 4c), containing three nucleotide substitutions within
one of the consensus p53-binding sites (474 to 465 bp).10
Similarly to primary T cells, exogenously expressed p73 was
recruited on endogenous bax gene promoter concomitantly
with the RNA pol II, thus evidencing its role in bax
transcriptional activation (Figure 4d, left panels). No binding
of transfected p73 on endogenous puma gene promoter was
observed (Figure 4d, right panel), thus indicating that p73
specifically induces bax transcription by directly binding the
bax promoter in the p53-binding sites.
RelA/NF-jB subunit antagonizes p73-induced bax
transcription and inhibits both p73 and RNA pol II
recruitment onto the bax gene promoter. We next tested
different NF-kB subunits for their ability to inhibit p73-induced
bax transcription. Jurkat cells were transfected with bax-
luciferase construct together with p73a in the presence or
absence of individual HA-tagged RelA, RelB plasmids or
expression vectors encoding for p50 or p52. RelA/p65
strongly interfered with p73-mediated bax transcription
when overexpressed in Jurkat cells (Figure 5a), whereas
the other NF-kB subunits did not exert any significant effects
Figure 1 CD28 interferes with IR-induced apoptosis by both inducing bcl-xL and inhibiting bax gene expressions. Human CD4þ T cells were exposed to 5 Gy of X-ray
radiation and cultured in the presence (B7) for different times. (a) RT-PCR analysis of bcl-xL, bax, bim, puma and GAPDH of irradiated T cells. (b) Post-irradiation (24 h) Bax,
p73, p53, RelA and tubulin protein expressions were analyzed by western blotting. Protein content was quantitated and expressed as fold induction (FI) over the basal level. (c)
Radioactive RT-PCR for p73 and GAPDH performed on mRNA extracted from irradiated T cells. The position of p73 splice variants (p73a: 535 bp; p73b: 440 bp and p73g:
386 bp) and molecular weight (MW) are shown. Radioactive PCR gel for p73 was exposed for 10 h. Data (a, c) were quantified and expressed as fold induction (FI) over
the basal level. (d) Anti-p73 and p53 ChIPs were analyzed by PCR with bax promoter-specific primers. Data were quantified and expressed as fold induction (FI) over
the basal level
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(Figure 5a and b). The increase in the bax-luciferase activity
observed in Jurkat cells overexpressing p50 and p52 was
related to a higher p73 expression (Figure 5b, right panels).
The bax gene promoter contains three putative binding
sites for NF-kB in the region comprised between 702 and
493 bp.10 To verify if NF-kB DNA-binding activity was
associated to the inhibition of p73-induced transcriptional
activation, a mutated bax-luciferase construct (Del-kB),
deleted of the putative NF-kB binding region, was generated.
Interestingly, the deletion of the NF-kB binding sites
significantly increases the ability of p73 to trans-activate the
bax gene promoter, whereas RelA inhibitory activity was
significantly reduced (Figure 6a). The apparent increase of
both HA-p73 and HA-RelA protein expression observed in
Del-kB-transfected cells (Figure 6b) was not due to higher
transfection efficiency, as verified by coexpressing an
enhanced green fluorescent protein (eGFP) construct (data
not shown). These data together with our observations that
RelA neither interacted with p73 nor affected the DNA-binding
affinity of p73 for the p53-binding site of the bax promoter in
Figure 2 CD28 promotes the recruitment of RelA to the bax gene promoter and interferes with p73-induced bax gene transcription. (a, b) Human T-cell blasts were
transfected with 5 mg of control siRNA specific for GFP (siRNA ctr) or 5mg of p73-specific siRNA duplexes (siRNA p73). After 48 h, p73, RelA and GAPDH expressions were
evaluated by western blotting (b) and T cells were exposed to 5 Gy X-ray radiation for further 24 h. Apoptosis induction was measured by PI staining and expressed as % of
hypodiploid DNA (a). (c, d) Human CD4þ T cells were exposed to 5 Gy X-ray radiation and cultured in the presence (B7) or absence (ctr) of adherent Dap/B7 cells for different
times. (c) Anti-p73, anti-pol II ChIPs were analyzed by PCR with bax promoter-specific primers. Data were quantified and expressed as fold induction (FI) over the basal level
(lower graph). (d) Anti-RelA ChIPs were analyzed by PCR with bax and bcl-xL promoter-specific primers. Data were quantified and expressed as fold induction (FI) over the
basal level (lower graph). (a–d) Data represent at least three independent experiments
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Figure 3 p73, but not p53, induces the transcriptional activation of bax gene in Jurkat cells. Jurkat cells were transfected with 10 mg bax-luciferase reporter construct
together with empty vector (vec) or 10mg HA-tagged p73 (ad) or 10mg Flag-tagged p53 expression vectors. After 8 h, luciferase activity (a) and anti-HA (b, upper panel),
anti-p53 (b, lower panel) and anti-GFP western blotting were analyzed. (a) The results are expressed as fold induction over the basal activity after normalization to GFP values.
The results express the mean±S.D. of three different experiments. (c) Jurkat cells were transfected with 10 mg DNp-73-luciferase reporter construct together with empty
vector (vec) or 10mg Flag-tagged p53. After 8 h, luciferase activity was analyzed. The results were expressed as the mean of arbitrary luciferase units±S.D. after
normalization to GFP values. (d) Human Cd4þ T cells were exposed to 5 Gy X-ray for different times. Anti-p53 ChIPs were analyzed by PCR with DNp73, or puma or p21
promoter-specific primers. Data were quantified and expressed as fold induction (FI) over the basal level
Figure 4 p73 binds the bax gene promoter and activates its transcription. (a) Luciferase activity of Jurkat cells transfected for 8 h with bax-luciferase reporter construct
together with empty vector or HA-tagged p73a or Flag-tagged D85p73a, deleted of the TAD. The results are expressed as the mean of arbitrary luciferase units±S.D. after
normalization to GFP values. The data represent at least four independent experiments. (b) An aliquot of each sample was analyzed by immunoblotting with anti-HA Ab for
p73a content or anti-Flag Ab forD85p73a content. (c) Jurkat cells were transfected for 8 h with bax-luciferase construct (wt) or bax-luciferase deleted of the p53-binding region
(mutp53) together with empty vector (vec) or HA-p73a vector. The results are expressed as fold induction over the basal activity after normalization to GFP values. The results
express the mean±S.D. of three different experiments. (d) Jurkat cells were transfected with HA-p73a expression vector, and ChIPs were performed using anti-p73 or anti-
RNA pol II antibodies after different times (0–24 h). Immunoprecipitated DNA was analyzed by PCR with either bax (left panel) or puma (right panel) promoter-specific primers,
quantified and expressed as fold induction (FI) over the basal level. Data are representative of five independent experiments
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gel shift (EMSA) assays (data not shown), suggested that the
inhibition of p73-mediated transcriptional activation of the bax
gene promoter could rely in part on the binding of RelA to the
bax promoter. To further verify this hypothesis, Jurkat cells
were transfected with p73a or RelA expression vectors alone
or in combination, and anti-p73 or anti-RelA ChIP assays were
performed on the endogenous bax gene promoter. RelA was
recruited to the endogenous bax promoter 8 h after transfec-
tion (Figure 6c, left upper panel, lane 2), and no significant
changes in its binding level were observed following the
coexpression of p73 (Figure 6c, left upper panel, lane 3). By
contrast, the recruitment of both p73 and RNA pol II was
inhibited in the presence of RelA (Figure 6c, right upper and
middle panels, lanes 3 versus 2).
Altogether these results indicate that exogenously
expressed RelA/NF-kB subunit antagonizes p73-induced
bax transcription by inhibiting p73 recruitment onto the bax
gene promoter but do not clarify the mechanisms of RelA-
mediated repression of bax expression in response to CD28
costimulation. One mechanism may involve the sequestration
of key p73 coactivators such as the p300/cAMP-responsive
element-binding protein-binding protein (CBP) and/or the
recruitment of corepressors histone deacetylase (HDAC) on
the bax promoter, as previously demonstrated in other
systems.20,21 As shown in Figure 6d, CD28 triggering
interfered with the recruitment of p73/p300 complexes to the
bax gene promoter and promoted the binding of HDAC-1-
containing complexes. Moreover, pretreatment of T cells with
the HDAC-1 inhibitor trichostatin A (TSA), strongly inhibited
the survival signals mediated by CD28 and restored
IR-induced Bax expression (Supplementary Figure 2).
The Akt pathway interferes with p73-mediated
transcription of bax gene by inducing RelA recruitment
to the bax promoter. The protein kinase B, Akt, has been
recently discovered as a critical mediator of survival in T
cells, acting specifically downstream of CD28 through the
activation of NF-kB.22,23 The involvement of Akt and NF-kB
in CD28 survival signals was supported by the observation
that the inhibitor of PI3K/Akt pathway, LY294002, as well as
MG101, a proteasome inhibitor that blocks RelA nuclear
translocation and transcriptional activity, without affecting
RelA expression (Supplementary Figure 2b, middle panel),
restored both IR-induced apoptosis and Bax protein levels
in CD28-costimulated T cells, without affecting p53 levels.
Finally, Akt overexpression in Jurkat cells completely
Figure 5 RelA/NF-kB inhibits p73-induced transcriptional activation of bax gene. Luciferase activity of Jurkat cells transfected for 8 h with bax-luciferase construct together
with empty vector (vec), or HA-p73a or HA-p73a plus 10mg HA-RelA, or HA-RelB (a) or p50 or p52 (b) expression vectors. The results are expressed as the mean of arbitrary
luciferase units±S.D. after normalization to GFP values. An aliquot of each sample was analyzed by immunoblotting with anti-HA Ab for p73a, RelA and RelB contents, anti-
p50 or anti-p52 Abs. The data represent at least four independent experiments
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inhibited both p73 binding (Figure 7b, upper panel, lanes 4
versus 3) and trans-activation of the bax gene (Figure 7a), by
inducing RelA recruitment to the bax promoter (Figure 7b,
middle panel, lanes 4 versus 2). A hypothetical model is
reported in Figure 7c.
Discussion
It is well established that members of the Bcl-2 protein family
are cardinal regulators of T-cell viability and the ratio of
antiapoptotic (Bcl-2, Bcl-xL) to proapoptotic (Bax, Bak)
members may be considered a rheostat that determines
susceptibility to cell death. Bcl-2 protein activities are
regulated by both transcriptional and post-translational
mechanisms. However, the mechanisms and the transcription
factors that regulate Bcl-2 family members at the promoter
level are not completely known, as well as the effects of
CD28 costimulation on the expression of other Bcl-2 family
members. In this article, we present evidence that CD28
engagement by B7 delivers survival signal in memory T cells
by both upregulating bcl-xL and inhibiting p73-mediated bax
gene transcription in a RelA/NF-kB-dependent manner.
In T cells, Bax is one of the major proapoptotic agents.
Bax deficiency alters both thymic selection and lymphoid
homeostasis.24 The presence of four motifs with homology to
consensus p53-binding site in the bax gene promoter and the
ability of p53 to trans-activate bax gene when overexpressed
in some cancer cell lines, identified bax as a p53 target
gene.10 The use of quantitative ChIP assays has recently
revealed that the bax gene promoter binds p53 very weakly,
when compared to other p53 target genes, such as noxa and
puma,11 which have been described as critical mediators of
the apoptotic responses induced by p53.25 Consistently, we
found that p53 was not recruited to the bax promoter in
irradiated T cells (Figure 1d), although it was able to trans-
activates bax gene when overexpressed in Cos7 cells or in
A2780 ovarian cancer cells (data not shown). Thus, our data
indicate that in human T cells p73 is the major regulator of bax
gene transcription and is involved in IR-induced apoptosis,
as demonstrated by the use of specific siRNA to inhibit p73
expression (Figure 2a). These data seem apparently in
contrast with those obtained from both p53- and p63/p73-
deficient mice.26,27 However, in both systems apoptosis was
analyzed only in IR-treated thymocyte26,27 or in mature T cells
following TCR restimulation.26,27 No data on the susceptibility
to IR-induced apoptosis of mature T cells have been shown.
We also show that p73 functions are counteracted by
RelA/NF-kB, thus reinforcing the current notions of a cross
talk between these two transcription factors in regulating
T-cell survival. RelA/NF-kB acts as a key prosurvival factor by
regulating the expression of antiapoptotic genes of the Bcl-2
family, in particular A1/Bfl-1 and bcl-xL. However, Bcl-xL
upregulation promotes T-cell survival28 but does not protect
T cells from activation-induced cell death (AICD).29,30 TCR-
AICD has been recently described to depend on both E2F-1
and p7314 and NF-kB may counteract TCR-driven apoptosis
Figure 6 RelA recruitment to the bax gene promoter inhibits both p73 binding and transcriptional activity. (a) Luciferase activity of Jurkat cells transfected with wt bax-
luciferase or bax-luciferase construct deleted of the putative NF-kB binding region (Del-kB) together with p73a or p73a and RelA constructs. The results are expressed as the
mean of arbitrary luciferase units±S.D. after normalization to GFP values. Data are representative of at least three independent experiments. (b) Each sample was analyzed
by immunoblotting with anti-HA Abs. (c) Anti-RelA, or anti-p73 or anti-RNA pol II ChIP assays were performed on Jurkat cells transfected for 8 h with HA-p73a or HA-RelA
expression vectors alone or in combination. Immunoprecipitated DNA was analyzed by PCR with bax promoter-specific primers. The data represent at least three independent
experiments. (d) Human memory CD4þ T cells were exposed to 5 Gy X-ray radiation and cultured in the presence (B7) or absence (ctr) of adherent Dap/B7 cells for different
times. Anti-p73, anti-p300 or anti-HDAC-1 ChIPs were analyzed by PCR with bax promoter-specific primers. (c, d) Data were quantified and expressed as fold induction (FI)
over the basal level
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by inhibiting p73 expression.15 Our data on the ability of RelA
to bind the bax gene promoter and to interfere with p73-
induced bax transcription evidence a novel mechanism by
which NF-kB may regulate T-cell survival. Indeed, RelA-
mediated inhibition of p73-induced bax gene expression is
accompanied by the recruitment of RelA to the bax gene
promoter and the parallel inhibition of p73 binding (Figure 2).
Moreover, the deletion of three potential NF-kB binding
sites from the bax gene promoter,7 restores significantly,
but not completely, p73-mediated transcriptional activation
(Figure 6a). The putative binding sites for NF-kB and p53/p73
within the bax promoter are very close.7 Thus, it is conceivable
that in on hand the binding of RelA to the bax gene promoter
might directly block p73 and RNA pol II recruitment through
a mechanism of steric hindrance, as observed for RelA-
mediated repression of glucocorticoid-receptor-dependent
transcription.31 In another hand, RelA may repress p73-
mediated transcription by both sequestering the coactivator
p300/CBP and favoring the recruitment of corepressor HDAC
complexes (Figure 6d), as observed in other systems.20,21
CD28 is an important regulator of T-cell survival by inducing
the expression of antiapoptotic proteins, in particular of
Bcl-xL.28 Data from Bcl-xL-deficient mice indicate that
Bcl-xL is essential for the survival of double-positive thymo-
cyte but not mature T lymphocytes.32 We have recently
demonstrated that CD28 stimulation, in the absence of TCR,
Figure 7 Akt induces RelA recruitment to the bax gene promoter and inhibits both p73 binding and trans-activation of the bax gene. (a) Bax-luciferase activity of Jurkat
cells transfected with empty vector (vec) p73a or p73a and Akt constructs. The results are expressed as the mean of arbitrary luciferase units±S.D. after normalization to GFP
values. Each sample was analyzed by immunoblotting with anti-p73 or anti-HA Abs (insert panel). (b) Jurkat cells were transfected with empty vector () or p73a or p73a plus
RelA or plus Akt for 8 h. Anti-p73 or anti-RelA ChIPs were analyzed by PCR with bax promoter-specific primers. Data were quantified and expressed as fold of induction (FI)
over the basal level. The data represent at least three independent experiments. (c) Schematic model of the CD28 signaling pathway leading to the recruitment of NF-kB/
HDAC-1 complexes on the bax gene promoter and to the inhibition of both p73/p300 and RNA pol II binding. The positions of NF-kB and p53 binding regions as well as TATA
box are indicated
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protects primary T cells from IR-mediated apoptosis by
inducing RelA-dependent transcription of bcl-xL.16 Here, we
demonstrate that CD28-delivered signals also inhibit p73-
induced bax expression in irradiated T cells, by interfering with
p73 and RNA pol II recruitment on the promoter (Figure 2).
These data evidence that CD28 is able to deliver a unique
signal leading to the induction of survival factors and
repression of proapoptotic genes.
A possible candidate in mediating CD28-protective signals
is Akt.22,23 Akt has been also described to inhibit Bax
translocation to mitochondria following serum deprivation.33
Our data on the restoration of both IR-induced apoptosis and
Bax levels in CD28-costimulated T cells treated with the PI3K
inhibitor LY294002 reveal a further role of Akt in regulating
Bax expression. Basu et al.34 have recently reported that
Akt phosphorylates the Yes-associated protein (YAP), thus
impairing its nuclear translocation and inhibiting its function as
strong transcriptional coactivator of p73.35 Thus, CD28-
mediated activation of Akt may lead to both the inactivation
of YAP and the recruitment of RelA-containing repressor
complexes31 on the bax gene promoter (Figure 7c), thereby
completely blocking p73-mediated transcriptional activity.
Materials and Methods
Cell lines, antibodies and reagents. Human primary CD4þ T cells were
enriched from peripheral blood mononuclear cells (PBMCs) by MACS microbead
sorting (Miltenyi Biotec, Milano, Italy) and cultured in RPMI 1640 supplemented with
5% human serum (Euroclone, UK), L-glutamine, penicillin and streptomycin (Gibco-
BRL, Grand Island, NY, USA). The purity of the sorted population was 95–99%. The
CD4þ Jurkat T cell line (clone J106.60) was maintained in RPMI 1640
supplemented with 10% FCS, L-glutamine, penicillin and streptomycin (Gibco-
BRL). Murine L cells and L cells expressing human B7.1 (Dap/B7) were previously
described.16 Anti-p65/RelA (C-20), anti-HA (Y11), anti-p73 (H-79), anti-p53 (DO-1),
anti-Bax, anti-Akt and anti-RNA pol II Abs were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Anti-p50 (06-886) and anti-p52 (05-361) Abs
were purchased from Upstate Biotechnology (Lake Placid, NY, USA). The PI3K
inhibitor LY294002 was from Calbiochem (La Jolla, CA, USA), TSA and the
proteasome inhibitor MG101 were purchased from Sigma.
Plasmids, cell transfection and luciferase assays. pcDNA3-
expressing HA-tagged human p73 isoforms (a, b, g , d), D84p73a–d isoforms
and FLAG-p53 have been previously described.12 HA-tagged p65/RelA and RelB as
well as p50 and p52 expression vectors were kindly provided by G Natoli
(Department of Experimental Oncology, European Institute of Oncology, Milan,
Italy). HA-tagged Akt construct was kindly provided by T Mustelin (The Burnham
Institute for Medical Research, La Jolla, CA, USA). Bax-luciferase reporter construct
was obtained by subcloning the PCR-generated fragment (715 to 317 bp) from
the bax gene promoter into BglII–HindIII sites of the pGL3-luciferase Enhancer
vector (Promega). Mutp53- and Del-kB-luciferase mutants were derived from bax-
luciferase construct by substituting three nucleotides within the consensus p53-
binding sites (474 to 465 bp),10 and deleting the three NF-kB binding sites
(708 to 502 bp),7 respectively, by PCR. The primers used were as follows:
mutp53 50-AAGTTAGAGATAATGCTGGGCGTAGG-30 and 50-CCTACGCCCAG
CATTATCTCTAACTT-30; Del-kB 50-ATTGGTACCATCTCTTGGGCTTCACAAG
TTA-30 and 50-TACCGGAATGCCAAGCTTACT-30. The entire sequences of the
mutants were verified by DNA sequencing.
Jurkat cells were transiently transfected with the indicated expression vectors
as previously described.36 Luciferase activity was measured according to the
manufacturer’s instruction (Promega). Transfection efficiency was controlled by
coexpressing pEGFP (Clontech), encoding an eGFP. Luciferase activity determined
in triplicates was expressed as fold induction over the basal activity of cells
transfected with empty vectors and/or as arbitrary luciferase units after
normalization to GFP values.
Semiquantitative PCR. The PCR mixture containing 50 mM KCl, 10 mM
Tris–HCl, 2.5 mM MgCl2, 0.2 mM dNTPs, 0.2mM 50 and 30 oligonucleotide primers
and 2.5 U Taq polymerase (Perkin-Elmer, Cetus, Norwalk, CT, USA) was amplified
in 0.5 ml GeneAmp tubes in a final volume of 50 ml. PCR mixtures were amplified by
35 cycles at 941C for 1 min, 601C for 30 s and 721C for 30 s. PCR was conducted in
the automated DNA Thermal Cycler GeneAmp PCR System 2400 (Perkin-Elmer).
Primers sequences were as follows: Bcl-xL 50-ATTGGTGAGTCGGATCGCAGC-30
and 50-AGAGAAGGGGGTGGGAGGGTA-30; Bax 50-ATGGTCACGGTCTGCCA-30
and 50-GACCCGGTGCCTCAGGA-30; Bim 50-GAGAAGGTAGACAATTGCAG-30 and
50-GACAATGTAACGTAACAGTCG-30; Puma 50-TGTAGAGGAGACAGGAATCC
ACGG-30 and 5%0-AGGCACCTAATTGGGCTCCATCTC-30 for GAPDH, specific
primers have been previously described.16 PCR products were size fractionated by
agarose electrophoresis and normalized according to the amount of GAPDH
detected in each sample.
p73 transcript analysis. To detect p73 splicing variant expression,
radioactive RT-PCR was performed, as previously described,12 using the
following primers: 50-TTCTGCAGGTGACTCAGGCTG-30 for RT; and 50-ACTT
TGAGATCCTGATGAAG-30 (sense primer) and 50-CAGATGGTCATGCGGTACTG-30
(antisense primer) for PCR amplification. cDNA synthesis was performed starting
with equal concentration of RNA (1 mg). Radioactive PCR was performed in 50ml of
reaction buffer containing 5ml of the RT product, 50 mM KCl, 10 mM Tris–HCl (pH
9.0), 0.1% Triton X-100, 1.5 mM MgCl2, dNTPs 0.2 mM each, cold primers 0.4mM
each, plus 40 nM each of [g-32P]dATP-labeled primers and 2.5 U of Taq DNA
polymerase. Amplifications consist of one cycle at 951C for 5 min followed by 35
cycles at 951C for 60 s, 591C for 55 s and 721C for 45 s. PCR products were
separated on a non-denaturating 6% polyacrylamide gel, dried and analyzed by
autoradiography.
Immunoblotting. Protein extracts were obtained by lysing cells for 30 min
at 41C in lysis buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40
(NP-40), 0.5% NaDoc and 1% SDS) in the presence of protease and phosphatase
inhibitors. Proteins were resolved by SDS-PAGE and blotted onto nitrocellulose
membranes. Blots were incubated with the indicated primary antibodies, extensively
washed and after incubation with horseradish peroxidase (HRP)-labeled goat
anti-rabbit or goat anti-mouse Abs (Amersham Pharmacia), developed with the
enhanced chemiluminescence’s detection system (Amersham Pharmacia).
ChIP assays. ChIP assays were performed as previously described.16 Briefly,
after fixing in 1% formaldehyde, cells were lysed for 5 min in 50 mM Tris, pH 8.0,
2 mM EDTA, 0.1% NP-40 and 10% glycerol supplemented with proteases inhibitors.
Nuclei were resuspended in 50 mM Tris, pH 8.0, 1% SDS and 5 mM EDTA.
Chromatin was sheared by sonication, centrifuged and diluted 10 times in 50 mM
Tris, pH 8.0, 0.5% NP-40, 0.2 M NaCl, 0.5 mM EDTA. After preclearing with a 50%
suspension of salmon sperm-saturated protein A, lysates were incubated at 41C
overnight with the indicated antibodies. Immune complexes were collected with
sperm-saturated protein A, washed three times with high-salt buffer (20 mM Tris, pH
8.0, 0.1% SDS, 1% NP-40, 2 mM EDTA, 500 mM NaCl) and five times with 1
Tris/EDTA (TE). Immune complexes were extracted in 1 TE containing 1% SDS,
and protein–DNA cross-links were reverted by heating at 651C overnight. DNA was
extracted by phenol–chloroform and about 1/20 of the immunoprecipitated DNA
was used in each PCR. The primers used were as follows: Bax promoter
50-CCCGGGAATTCCAGACTGCAG-30 and 50-GAGCTCTCCCCAGCGCAGAAG-30;
Bcl-xL promoter 50-GCACCACCTACATTCAAATCC-30 and 50-CGATGGAGGAGG
AAGCAAGC-30. Puma promoter 50-GAACGCCCGTCGGTCGGTCTGT-30 and
50-CAAGTCAGGACTTGCAGGCGC-30; DNp73 promoter 50-CTCCTCTCCATGCA
GCCCTTGGAC-30 and 50-CCAACAACAAAACCCGCGGCCCAC-30.
Apoptosis analysis. Human CD4þ T cells were exposed to 5 Gy of IR by
using an X-ray apparatus (AL filter 3 mm) and then cultured in the presence (B7) or
absence (ctr) of adherent Dap/B7 cells for 24 h. Where indicated cells were
pretreated for 2 h with either LY294002 (50 mM) or TSA (100 nM) or MG101 (10mM)
before IR. At the end of incubation, cells were carefully resuspended in PBS
containing 0.1% Triton X-100 (Sigma) and 100 U/ml RNase A (Sigma), were stained
with 50mg/ml propidium iodide (PI; Sigma) and incubated at 371C for 15 min.
Apoptosis was analyzed by a BD Biosciences FACScalibur (BD Biosciences,
Mountain View, CA, USA), by a biparametric analysis of FL2-H versus SSC-H
graphs. Cells showing a less than 2C DNA content (hypodiploid cells) and high
SSC-H (granular, highly condensed cells) were regarded as apoptotic. The mean
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frequencies of apoptotic cells were calculated at least from three independent
experiments and statistically analyzed using Student’s t-test. The percentage of
specific apoptosis was calculated as follows: % specific apoptosis¼ 100 (% PIþ
cells% spontaneous PIþ untreated cells)/(100% spontaneous PIþ untreated
cells).
siRNA transfection. p73 siRNA and Bax sMART pool siRNA oligonucleotides
were purchased from Dharmacon (Chicago, IL, USA) and designed on the
sequence of human p73 cDNA encoding the DNA-binding domain (siRNA p73) or
GFP (siRNA ctr). The sense strand sequences of the siRNAs were as follows: p73
50-CCAUCCUGUACAACUUCAUGUG-30 and GFP 50-GTTCAGCGTGTCCGG
CGAG-30. The two siRNAs specific for p53 (A and B) were kindly provided by G
Blandino (Department of Experimental Oncology, Regina Elena Cancer Institute,
Rome, Italy) and sequences are available upon request.
Primary T-cell blasts were isolated by MACS microbead sorting from PBMCs
activated for 4 days with 1mg/ml phytohemagglutinin and 5 IU/ml recombinant IL-2
(Roche). Cationic lipid complexes, prepared by incubating 5 mg of indicated siRNA
with 10ml Lipofectamine (Invitrogen) in 600ml Optimem (Invitrogen) for 1 h, were
added to 107 T-cell blasts in a final volume of 5 ml. After overnight incubation, cells
were washed and cultured in RPMI containing 1% FCS for further 24 h. At the end of
incubation, p73 expression was analyzed by western blotting, and T cells were
exposed to 5 Gy IR and after 24 h apoptosis was evaluated by PI staining.
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